查看文章

Almost 50 million people are living with dementia in 2018 worldwide, and the number will double every 20 years. The effectiveness of existing pharmacologic treatments for the disease is limited to symptoms control, and none of them are able to prevent, reverse or turn off the neurodegenerative process that leads to dementia; therefore, a prompt detection of the “disease signature” is a key problem, in order to develop and test new drugs and to support the management of clinical and domestic context. Recent studies showed that linguistic alterations may be one of the earliest signs of the pathology, years before other neurocognitive deficits become evident. Traditional tests fail to identify these slight but noticeable changes; whereas, the analysis of spoken language productions by Natural Language Processing (NLP) techniques can ecologically and inexpensively identify minor language modifications in potential …